Fun with fermentations: Black coffee in bed with help from microbes

Australia is, for reasons I’ll never understand, a country of coffee snobs, with their baristas and their 20-minute preparation times and the $4.50 a cup.

No Tim Hortons here (sadly, the co-founder of the venerable Canadian chain passed away today).

According to research published February 1 in the journal, Applied and Environmental Microbiology, when processing coffee beans, longer fermentation times can result in better taste, contrary to conventional wisdom. Lactic acid bacteria play an important, positive role in this process. Other species of microbes may play a role in this process as well, but more research is needed to better understand their role.

“A cup of coffee is the final product of a complex chain of operations: farming, post-harvest processing, roasting, and brewing,” said principal investigator Luc De Vuyst, M.Sc., Ph.D., Professor of Industrial Microbiology and Food Biotechnology, Vrije Universiteit Brussel, Brussels, Belgium. “There are several variants of post-harvest processing, among which wet processing and dry processing are the most common.” Wet processing—commonly used for Arabica and specialty coffees—is the step that includes fermentation.

“We carried out the research at an experimental farm in Ecuador through a multiphasic approach, encompassing microbiological, metabolomics, and sensory analysis,” said Dr. De Vuyst.

Fermentation was of particular importance. During extended fermentation, leuconostocs—a genus of lactic acid bacteria used in the fermentation of cabbage to sauerkraut and in sourdough starters—declined in favor of lactobacilli, said Dr. De Vuyst. Lactic acid bacteria were already present before fermentation, and these acid tolerant lactobacilli proliferated even more during this process.

However, it is challenging to draw a causal link between the microbiota and the volatile compounds in the beans—those compounds that contribute to the coffee’s smell – since many of these compounds can be of microbial, endogenous bean metabolism, or chemical origin,” said Dr. De Vuyst.

“However, we did see an impact of the microbial communities, in particular the lactic acid bacteria,” said Dr. De Vuyst. They yielded fruity notes, and may have “had a protective effect toward coffee quality during fermentation because of their acidification of the fermenting mass, providing a stable microbial environment and hence preventing growth of undesirable microorganisms that often lead to off-flavors,” he said.
“Furthermore, there is a build-up of the fermentation-related metabolites onto the coffee beans, which affects the quality of the green coffee beans and hence the sensory quality of the coffees brewed therefrom,” said Dr. De Vuyst.

Dr. De Vuyst emphasized that how each stage of processing influences the taste of coffee remains mostly uncharted. “We were aware of many different microorganisms during wet coffee fermentation — enterobacteria, lactic acid bacteria, yeasts, acetic acid bacteria, bacilli, and filamentous fungi,” said Dr. De Vuyst, but it is still unknown how most bacteria influence this process.

The work was a collaboration between the Vrije Universiteit Brussel, and Nestlé Research. “Nestlé was interested in the fundamental aspects of coffee processing, in particular, the post-harvest processing chain, in order to correlate it with the roasting process and of course the final cup quality,” said Dr. De Vuyst.

Statement of the American Society for Microbiology on the national strategy to combat antibiotic resistant bacteria

The American Society for Microbiology (ASM) congratulates the Obama Administration for its September 18 announced White House National Strategy for Combating Antibiotic Resistant Bacteria (CARB).   The strategy outlines bold steps to slow the public health threat of antibiotic resistant bacteria, including efforts to stimulate innovative research.   Importantly, the Strategy will establish a new Task Force for Combatting Antibiotic Resistant Bacteria which is directed to submit an action plan to the President by February 2015. This elevated attention at the highest level of government is needed because in the United States alone, antibiotic resistant bacteria cause 2 million infections a year and 23,000 deaths.

ab.res.prudent.may.14Innovative research is needed to discover new, effective antibiotics and to ensure existing antibiotics are properly targeted. Research will lead to innovative diagnostics to improve detection and tracking of pathogens, new vaccines targeted to drug resistant organisms and new antibiotics in partnership with private industry. Cutting edge genetic sequencing technologies used at point of care can enhance surveillance of antimicrobial resistance, enabling rapid tracking of genetic signatures and ensure rapid, accurate diagnosis and appropriate use of antibiotics saving lives and reducing resistance resulting from inappropriate treatment.  Because an estimated half of antibiotic prescriptions are inappropriate, encouraging the development of rapid, point of care tests is critical to identifying and tailoring treatment of resistant bacteria and minimizing the use of broad spectrum antibiotics.  

The National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) will play leading roles in the national response. The collaborative efforts of the these agencies will be extremely important to advance development and use of rapid diagnostic tests for identifying drug resistant infections. Enhanced regulatory processes and reduction in approval cycle time will be key. Reimbursement of new diagnostic tests will also be a major incentive for development of new diagnostics by the private sector. The recommended expansion of DNA sequencing capacity and collection of microbial genetic sequences in a centralized National Database of Resistant Pathogens will allow comparison of outbreak stains with the database collection, improving their control.

The emphasis on tracking resistance in humans, animals and food and promoting antibiotic stewardship across the food chain is vitally important, as well as minimizing antibiotic use for non-health purposes. The President’s Executive Order calls for work internationally, recognizing that efforts must be global to reduce the burden of antimicrobial resistance and its spread.

The National Strategy articulates national goals, priorities and specific objectives that provide an overarching framework for federal investments to combat antimicrobial disease. It will be extremely important that new and adequate funding is provided to accomplish this comprehensive agenda. The ASM appreciates the new initiatives and is committed to working with federal agencies and Congress as this ambitious agenda to address the threat of antimicrobial resistance gets underway.